vs

Side-by-side financial comparison of Option Care Health, Inc. (OPCH) and STIFEL FINANCIAL CORP (SF). Click either name above to swap in a different company.

Option Care Health, Inc. is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.2× STIFEL FINANCIAL CORP). STIFEL FINANCIAL CORP runs the higher net margin — 23.5% vs 3.4%, a 20.1% gap on every dollar of revenue. On growth, STIFEL FINANCIAL CORP posted the faster year-over-year revenue change (23.0% vs 1.3%). Over the past eight quarters, STIFEL FINANCIAL CORP's revenue compounded faster (21.1% CAGR vs 4.9%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Stifel Financial Corp. is an American multinational independent investment bank and financial services company created under the Stifel name in July 1983 and listed on the New York Stock Exchange on November 24, 1986. Its predecessor company was founded in 1890 as the Altheimer and Rawlings Investment Company and is headquartered in downtown St. Louis, Missouri.

OPCH vs SF — Head-to-Head

Bigger by revenue
OPCH
OPCH
1.2× larger
OPCH
$1.4B
$1.1B
SF
Growing faster (revenue YoY)
SF
SF
+21.7% gap
SF
23.0%
1.3%
OPCH
Higher net margin
SF
SF
20.1% more per $
SF
23.5%
3.4%
OPCH
Faster 2-yr revenue CAGR
SF
SF
Annualised
SF
21.1%
4.9%
OPCH

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
OPCH
OPCH
SF
SF
Revenue
$1.4B
$1.1B
Net Profit
$45.3M
$264.4M
Gross Margin
19.4%
Operating Margin
5.4%
27.3%
Net Margin
3.4%
23.5%
Revenue YoY
1.3%
23.0%
Net Profit YoY
-3.0%
8.3%
EPS (diluted)
$0.29
$2.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPCH
OPCH
SF
SF
Q1 26
$1.4B
Q4 25
$1.5B
$1.1B
Q3 25
$1.4B
$962.6M
Q2 25
$1.4B
$838.9M
Q1 25
$1.3B
$842.5M
Q4 24
$1.3B
$916.0M
Q3 24
$1.3B
$810.9M
Q2 24
$1.2B
$798.9M
Net Profit
OPCH
OPCH
SF
SF
Q1 26
$45.3M
Q4 25
$58.5M
$264.4M
Q3 25
$51.8M
$211.4M
Q2 25
$50.5M
$155.1M
Q1 25
$46.7M
$53.0M
Q4 24
$60.1M
$244.0M
Q3 24
$53.9M
$158.5M
Q2 24
$53.0M
$165.3M
Gross Margin
OPCH
OPCH
SF
SF
Q1 26
19.4%
Q4 25
19.3%
Q3 25
19.0%
Q2 25
19.0%
Q1 25
19.7%
Q4 24
21.3%
Q3 24
20.1%
Q2 24
20.3%
Operating Margin
OPCH
OPCH
SF
SF
Q1 26
5.4%
Q4 25
6.2%
27.3%
Q3 25
5.9%
29.7%
Q2 25
5.8%
25.5%
Q1 25
5.9%
7.5%
Q4 24
6.9%
29.1%
Q3 24
6.7%
26.7%
Q2 24
6.6%
28.4%
Net Margin
OPCH
OPCH
SF
SF
Q1 26
3.4%
Q4 25
4.0%
23.5%
Q3 25
3.6%
22.0%
Q2 25
3.6%
18.5%
Q1 25
3.5%
6.3%
Q4 24
4.8%
26.6%
Q3 24
4.2%
19.5%
Q2 24
4.3%
20.7%
EPS (diluted)
OPCH
OPCH
SF
SF
Q1 26
$0.29
Q4 25
$0.37
$2.30
Q3 25
$0.32
$1.84
Q2 25
$0.31
$1.34
Q1 25
$0.28
$0.39
Q4 24
$0.36
$2.10
Q3 24
$0.31
$1.34
Q2 24
$0.30
$1.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPCH
OPCH
SF
SF
Cash + ST InvestmentsLiquidity on hand
$177.3M
$2.3B
Total DebtLower is stronger
$617.4M
Stockholders' EquityBook value
$6.0B
Total Assets
$3.4B
$41.3B
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPCH
OPCH
SF
SF
Q1 26
$177.3M
Q4 25
$232.6M
$2.3B
Q3 25
$309.8M
$3.2B
Q2 25
$198.8M
$1.9B
Q1 25
$171.4M
$2.7B
Q4 24
$412.6M
$2.6B
Q3 24
$483.0M
$1.9B
Q2 24
$376.9M
$2.6B
Total Debt
OPCH
OPCH
SF
SF
Q1 26
Q4 25
$617.4M
Q3 25
$1.2B
$617.2M
Q2 25
$1.1B
$617.0M
Q1 25
$1.1B
$616.8M
Q4 24
$1.1B
$616.6M
Q3 24
$1.1B
$616.4M
Q2 24
$1.1B
$1.1B
Stockholders' Equity
OPCH
OPCH
SF
SF
Q1 26
Q4 25
$1.3B
$6.0B
Q3 25
$1.4B
$5.8B
Q2 25
$1.4B
$5.6B
Q1 25
$1.4B
$5.5B
Q4 24
$1.4B
$5.7B
Q3 24
$1.4B
$5.6B
Q2 24
$1.4B
$5.4B
Total Assets
OPCH
OPCH
SF
SF
Q1 26
$3.4B
Q4 25
$3.5B
$41.3B
Q3 25
$3.5B
$41.7B
Q2 25
$3.4B
$39.9B
Q1 25
$3.3B
$40.4B
Q4 24
$3.4B
$39.9B
Q3 24
$3.4B
$38.9B
Q2 24
$3.3B
$37.8B
Debt / Equity
OPCH
OPCH
SF
SF
Q1 26
Q4 25
0.10×
Q3 25
0.86×
0.11×
Q2 25
0.82×
0.11×
Q1 25
0.82×
0.11×
Q4 24
0.79×
0.11×
Q3 24
0.78×
0.11×
Q2 24
0.79×
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPCH
OPCH
SF
SF
Operating Cash FlowLast quarter
$382.4M
Free Cash FlowOCF − Capex
$369.0M
FCF MarginFCF / Revenue
32.7%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
1.45×
TTM Free Cash FlowTrailing 4 quarters
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPCH
OPCH
SF
SF
Q1 26
Q4 25
$258.4M
$382.4M
Q3 25
$139.4M
$338.3M
Q2 25
$90.3M
$607.5M
Q1 25
$-7.2M
$-211.2M
Q4 24
$36.1M
$694.6M
Q3 24
$160.4M
$198.3M
Q2 24
$195.7M
$207.2M
Free Cash Flow
OPCH
OPCH
SF
SF
Q1 26
Q4 25
$369.0M
Q3 25
$130.2M
$321.1M
Q2 25
$81.2M
$592.7M
Q1 25
$-16.6M
$-227.8M
Q4 24
$25.8M
$677.2M
Q3 24
$150.7M
$185.6M
Q2 24
$185.9M
$173.3M
FCF Margin
OPCH
OPCH
SF
SF
Q1 26
Q4 25
32.7%
Q3 25
9.1%
33.4%
Q2 25
5.7%
70.6%
Q1 25
-1.2%
-27.0%
Q4 24
2.0%
73.9%
Q3 24
11.8%
22.9%
Q2 24
15.1%
21.7%
Capex Intensity
OPCH
OPCH
SF
SF
Q1 26
Q4 25
1.2%
Q3 25
0.6%
1.8%
Q2 25
0.6%
1.8%
Q1 25
0.7%
2.0%
Q4 24
0.8%
1.9%
Q3 24
0.8%
1.6%
Q2 24
0.8%
4.2%
Cash Conversion
OPCH
OPCH
SF
SF
Q1 26
Q4 25
4.42×
1.45×
Q3 25
2.69×
1.60×
Q2 25
1.79×
3.92×
Q1 25
-0.15×
-3.99×
Q4 24
0.60×
2.85×
Q3 24
2.98×
1.25×
Q2 24
3.69×
1.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons